News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,346 Results
Type
Article (43293)
Company Profile (283)
Press Release (695753)
Multimedia
Podcasts (91)
Webinars (24)
Section
Business (208006)
Career Advice (2071)
Deals (35967)
Drug Delivery (128)
Drug Development (82029)
Employer Resources (176)
FDA (16670)
Job Trends (15180)
News (351218)
Policy (33088)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2705)
Academic (1)
Accelerated approval (44)
Adcomms (26)
Allergies (162)
Alliances (50958)
ALS (195)
Alzheimer's disease (1769)
Antibody-drug conjugate (ADC) (380)
Approvals (16990)
Artificial intelligence (646)
Autoimmune disease (232)
Automation (53)
Bankruptcy (363)
Best Places to Work (11809)
BIOSECURE Act (20)
Biosimilars (209)
Biotechnology (186)
Bladder cancer (178)
Brain cancer (66)
Breast cancer (697)
Cancer (5433)
Cardiovascular disease (451)
Career advice (1757)
Career pathing (40)
CAR-T (305)
CDC (57)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (43)
Clinical research (70618)
Collaboration (1982)
Company closure (4)
Compensation (1299)
Complete response letters (71)
COVID-19 (2767)
CRISPR (102)
C-suite (1021)
Cystic fibrosis (149)
Data (7159)
Decentralized trials (3)
Denatured (30)
Depression (158)
Dermatology (63)
Diabetes (551)
Diagnostics (7052)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (306)
Drug pricing (195)
Drug shortages (30)
Duchenne muscular dystrophy (267)
Earnings (91646)
Editorial (62)
Employer branding (21)
Employer resources (153)
Events (120197)
Executive appointments (1064)
FDA (20153)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1666)
Gene editing (217)
Generative AI (57)
Gene therapy (666)
GLP-1 (1032)
Government (4765)
Grass and pollen (6)
Guidances (399)
Healthcare (19287)
HIV (76)
Huntington's disease (53)
IgA nephropathy (91)
Immunology and inflammation (275)
Immuno-oncology (84)
Indications (161)
Infectious disease (3088)
Inflammatory bowel disease (202)
Inflation Reduction Act (14)
Influenza (131)
Intellectual property (278)
Interviews (322)
IPO (16757)
IRA (50)
Job creations (3691)
Job search strategy (1462)
JPM (58)
Kidney cancer (18)
Labor market (93)
Layoffs (559)
Leadership (36)
Legal (7993)
Liver cancer (99)
Longevity (29)
Lung cancer (724)
Lymphoma (407)
Machine learning (55)
Management (60)
Manufacturing (955)
MASH (178)
Medical device (14102)
Medtech (14182)
Mergers & acquisitions (20398)
Metabolic disorders (1424)
mRNA (177)
Multiple sclerosis (176)
NASH (17)
Neurodegenerative disease (388)
Neuropsychiatric disorders (99)
Neuroscience (3191)
Neurotech (1)
NextGen: Class of 2026 (6677)
Non-profit (4639)
Now hiring (74)
Obesity (670)
Opinion (285)
Ovarian cancer (192)
Pain (232)
Pancreatic cancer (259)
Parkinson's disease (348)
Partnered (33)
Patents (566)
Patient recruitment (606)
Peanut (61)
People (60399)
Pharmaceutical (61)
Pharmacy benefit managers (32)
Phase 1 (22062)
Phase 2 (31090)
Phase 3 (23119)
Pipeline (7325)
Policy (306)
Postmarket research (2579)
Preclinical (9447)
Press Release (68)
Prostate cancer (279)
Psychedelics (49)
Radiopharmaceuticals (314)
Rare diseases (1006)
Real estate (6083)
Recruiting (70)
Regulatory (25313)
Reports (55)
Research institute (2516)
Resumes & cover letters (357)
Rett syndrome (33)
RNA editing (17)
RSV (86)
Schizophrenia (164)
Series A (276)
Series B (208)
Service/supplier (11)
Sickle cell disease (108)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (46)
Startups (3702)
State (2)
Stomach cancer (18)
Supply chain (122)
Tariffs (87)
The Weekly (59)
Vaccines (1072)
Venture capital (98)
Weight loss (428)
Women's health (113)
Worklife (20)
Date
Today (96)
Last 7 days (526)
Last 30 days (2584)
Last 365 days (30468)
2026 (8631)
2025 (30639)
2024 (35620)
2023 (40574)
2022 (51676)
2021 (56277)
2020 (54840)
2019 (47547)
2018 (35740)
2017 (32700)
2016 (32117)
2015 (38225)
2014 (31855)
2013 (27020)
2012 (29209)
2011 (29902)
2010 (27893)
Location
Africa (764)
Alabama (92)
Alaska (7)
Arizona (332)
Arkansas (13)
Asia (40555)
Australia (6626)
California (12475)
Canada (3550)
China (1264)
Colorado (530)
Connecticut (532)
Delaware (378)
Europe (88479)
Florida (1878)
Georgia (402)
Hawaii (3)
Idaho (63)
Illinois (982)
India (86)
Indiana (574)
Iowa (23)
Japan (502)
Kansas (132)
Kentucky (46)
Louisiana (40)
Maine (74)
Maryland (1514)
Massachusetts (8940)
Michigan (351)
Minnesota (691)
Mississippi (6)
Missouri (141)
Montana (34)
Nebraska (29)
Nevada (141)
New Hampshire (83)
New Jersey (3323)
New Mexico (29)
New York (3297)
North Carolina (1592)
North Dakota (9)
Northern California (6165)
Ohio (377)
Oklahoma (24)
Oregon (42)
Pennsylvania (2517)
Puerto Rico (27)
Rhode Island (50)
South America (1148)
South Carolina (80)
South Dakota (1)
Southern California (4908)
Tennessee (201)
Texas (1989)
United States (44274)
Utah (377)
Vermont (1)
Virginia (299)
Washington D.C. (81)
Washington State (1000)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
739,346 Results for "integral molecular inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
March 10, 2026
·
7 min read
Press Releases
Mimulus and GenScript Partner to Scale the World’s First Zero-Watt Molecular Archive Infrastructure for the AI Era
April 9, 2026
·
5 min read
Press Releases
Moolec Science Announces Breakthrough in Molecular Farming With Successful Expression of Bovine Myoglobin in Pea Seeds
April 7, 2026
·
4 min read
Press Releases
Microbix Presents Molecular Pathology Platform Results
February 4, 2026
·
5 min read
Press Releases
Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio
February 24, 2026
·
2 min read
Press Releases
bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
April 10, 2026
·
3 min read
Press Releases
Caris Life Sciences Introduces Multimodal AI-Powered Molecular Insight to Identify the Benefit or Harm from the Addition of Chemotherapy for NSCLC Patients
April 8, 2026
·
6 min read
Press Releases
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
March 26, 2026
·
6 min read
Deals
Roche sticks with C4T, adding up to $1B for molecular glue partnership
Roche is jumping into degrader-antibody conjugates, a modality that in recent years has attracted investments from Merck KGaA and Bristol Myers Squibb.
April 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
March 3, 2026
·
7 min read
1 of 73,935
Next
